diplomsko delo
Urša Petrovič (Author), Mojca Narat (Mentor), Mojca Narat (Thesis defence commission member), Branka Javornik (Thesis defence commission member), Polona Jamnik (Thesis defence commission member)

Abstract

Probiotiki so živi mikroorganzimi, ki ob prejemu v zadostni količini nudijo pozitivne vplive na zdravje gostitelja. Preko interakcije z gostiteljevim gastrointestinalnim traktom so sposobni vplivati na njegov prirojeni in pridobljeni immunski odziv. Probiotki vplivajo na sposobnost fagocitoze makrofagov in drugih celic, vplivajo na število in učinkovitost celic NK, spodbujajo produkcijo citokinov in protiteles IgA, preko celic DC vplivajo na celice Treg, ter uravnavajo ravnovesje med Th1 in Th2 celičnimi sub-populacijami. Delovanje probiotikov je sevno specifično. L. reuteri, je na primer zaviral produkcijo citokina IL-8, medtem ko jo je sev L. plantarum 299v spodbujal. Nekateri probiotiki imajo sposobnost uravnavati imunski odziv, glede na zdravstveno stanje gostitelja. L. rhamnosus GG je pri zdravih posameznikih stimuliral fagocitozno aktivnost ter jo inhibiral pri preobčutljivih na mleko. Najbolj pogosto uporabljeni probiotiki so G+ mlečnokislinske bakterije iz rodu Lactobacillus in Bifidobacterium, vendar tudi G- bakterije, na primer E. coli Nissle 1917, veliko obetajo, saj kažejo večje imunostimulatorne učinke; verjetno zaradi različnih PAMP na njihovi površini. Probiotiki s svojimi imunomodulatornimi lastnostmi kažejo velik potencial za uporabo pri zdravljenju različnih bolezni (diareja, ulcerozni kolitis, preobčutljivosti, alergije, atopični dermatitis, avtoimunske bolezni idr.), uporabni pa bi bili tudi kot adjuvanti oralnim cepivom.

Keywords

probiotiki;imunomodulacija;prebiotiki;imunski sistem;Lactobacillus;Bifidobacterium;Escherichia coli Nissle 1917;

Data

Language: Slovenian
Year of publishing:
Typology: 2.11 - Undergraduate Thesis
Organization: UL BF - Biotechnical Faculty
Publisher: [U. Petrovič]
UDC: 602.3:579.864:606:61:579.6(043.2)
COBISS: 8806521 Link will open in a new window
Views: 1117
Downloads: 470
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: English
Secondary title: Probiotics and immunomodulation
Secondary abstract: Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. Through interaction with the host gastrointestinal tract, they are able to influence its innate and adaptive immune response. Probiotics affect the ability of phagocytosis of macrophages and other cells, affect the number and efficiency of NK cells, stimulate the production of cytokines and IgA antibodies, affect the Treg cells via DC cells, and balance Th1 and Th2 sub-populations. Probiotics are strain specific. L. reuteri, for example, inhibited the production of cytokine IL-8, while the strain L. plantarum 299v stimulated it. Some probiotics have the ability to control the immune response, depending on the health status of the host. L. rhamnosus GG stimulated phagocytosis in healthy individuals and inhibited it in milk-hypersensitive patients. The most commonly used probiotics are G + lactic acid bacteria from the genus Lactobacillus and Bifidobacterium, but also G-bacteria, for example E. coli Nissle 1917, are very promising, as they show greater immunostimulatory effects; probably due to different PAMPs on their surface. Probiotics, with their immunomodulatory properties, show great potential for use in the treatment of various diseases (diarrhea, ulcerative colitis, hypersensitivity, allergies, atopic dermatitis, autoimmune diseases, etc.) and they would also be useful as adjuvants to oral vaccines.
Secondary keywords: probiotics;immunomodulation;prebiotics;immune system;Lactobacillus;Bifidobacterium;Escherichia coli Nissle 1917;
Type (COBISS): Bachelor thesis/paper
Study programme: 0
Thesis comment: Univ. v Ljubljani, Biotehniška fak., Študij biotehnologije
Pages: VIII, 20 str., [1] f. pril.
ID: 10910289
Recommended works:
, diplomsko delo
, antimicrobial efficacy and prevalence among isolates from patients with bacteraemia